PLL Therapeutics focuses on restoring gut permeability. Its initial indication is Amyotrophic Lateral Sclerosis (ALS), a fatal motor neuron disease. The company’s therapy, PLL001, consists of several ...

Alabama Governor Kay Ivey released a statement following the death of former State Finance Director Kelly Butler.Ivey said ...

The EMA recommended that NUZ-001, formerly monepantel, be granted orphan medicinal product designation to treat ALS in Europe ...

Ractigen Therapeutics, a clinical-stage pharmaceutical company dedicated to developing innovative therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...

The St. Peter’s Hospital ALS Regional Center gives specialized services and resources to people with Amyotrophic Lateral ...

Positive preclinical results in human in vitro iPSC Motor Neuron models of Amyotrophic Lateral Sclerosis (ALS) Neurizon's lead drug NUZ-001 and its major active metabolite significantly and ...

Lee Wilson discovered she has a "100%" chance of developing ALS, after losing her father and grandmother to the disease ...

ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord, ultimately leading to muscle weakness and paralysis. ALS is an orphan disease, but its ...

The original run was started in 2010, a combined fundraiser for the 4S Ranch-Del Sur Community Foundation and Helen’s Closet, ...

Biopharmaceutical company Trace Neuroscience announced it has raised $101 million in a Series A financing effort to develop ...

He has also worked as assistant finance director for fiscal operations and state budget officer. ALS, or amyotrophic lateral ...

A new AI-powered interpreter is expected to simulate speakers’ voices in different languages during Microsoft Teams meetings.